Variable
Population (n=200)
Median SARS-CoV-2 PCR Ct, A
B
C
18.9 (17.9-19.5) 22.9 (22.0-25.2) 34.0 (30.8-36.9)
Hospital admissions, n 127 (63.5%)
Symptomatic, n 180 (90.0%)
Signs and symptoms according to main systems, n Systemic inflammatory involvement
Neurological involvement
Gastroenterological involvement
Respiratory involvement
166 (83.0%) 73 (36.5%) 35 (17.5%) 131 (65.5%)
Time between symptoms onset and diagnostic swab, days* 5 (3-8)
Outcomes, n Complete recovery
Sequelae
Death
127 (63.5%) 41 (20.5%) 32 (16.0%)
Type of Sequelae, n Dyspnoea
Olfactory and/or gustatory dysfunction
Chronic cough
Others°
21 (12.5%) 13 (7.7%) 7 (4.2%) 6 (3.6%)
Worst oxygen support, n None
Wall low-flow oxygen to reservoir
CPAP
Intubation
99 (49.5%) 60 (30.0%) 29 (14.5%) 12 (6.0%)
Comorbidities, n None
Hypertension
COPD/asthma
Overweight/obesity
Active smoking
Diabetes
Cancer
Others
82 (41.0%) 56 (28.0%) 33 (16.5%) 27 (13.5%) 23 (11.5%) 19 (9.5%) 17 (8.5%) 46 (23.0%)
Disease severity, n Home isolation
Hospital admission without oxygen support
Hospital admission with low-flow oxygen to reservoir
Hospital admission with CPAP
Hospital admission with intubation
Death
73 (36.5%) 26 (13.0%) 39 (19.5%) 20 (10.0%) 10 (5.0%) 32 (16.0%)